Cargando…

Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI

BACKGROUND: To evaluate the utility of the pharmacokinetic modeling derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiating benign from malignant adnexal masses. METHODS: A total of 43 patients with 49 complex adnexal masses (27 benign, 3 borderline, and 19 mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Gity, Masoumeh, Parviz, Sara, Saligheh Rad, Hamidreza, Fathi Kazerooni, Anahita, Shirali, Elham, Shakiba, Madjid, Baikpour, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948906/
https://www.ncbi.nlm.nih.gov/pubmed/31030476
http://dx.doi.org/10.31557/APJCP.2019.20.4.1073
_version_ 1783485822560894976
author Gity, Masoumeh
Parviz, Sara
Saligheh Rad, Hamidreza
Fathi Kazerooni, Anahita
Shirali, Elham
Shakiba, Madjid
Baikpour, Masoud
author_facet Gity, Masoumeh
Parviz, Sara
Saligheh Rad, Hamidreza
Fathi Kazerooni, Anahita
Shirali, Elham
Shakiba, Madjid
Baikpour, Masoud
author_sort Gity, Masoumeh
collection PubMed
description BACKGROUND: To evaluate the utility of the pharmacokinetic modeling derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiating benign from malignant adnexal masses. METHODS: A total of 43 patients with 49 complex adnexal masses (27 benign, 3 borderline, and 19 malignant lesions) underwent preoperative DCE-MRI examinations on a 3 Tesla MRI. Using extended Tofts’ model, quantitative analysis was performed in the solid components of all tumors. Three pharmacokinetic parameters were defined as volume transfer coefficient (Ktrans), the rate constant (Kep), and the plasma volume (Vp). Semi-quantitative analysis was also performed and the values of relative signal intensity (SI rel) wash-in-rate (WIR), the initial area under the curve (iAUC60), time-to-peak (TTP) and wash-out-rate (WOR) were calculated. Receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic characteristics of each DCE-MRI parameter in differentiating borderline/malignant tumors from benign lesions and to provide the optimal cutoff values for these variables. RESULTS: SI rel had the highest diagnostic value (AUC=0.872; p<0.001; cut-off=121.4 associated with an overall accuracy=79.6%, sensitivity=95.5%, specificity=66.7%, NPV=94.8% and PPV=70.0%). Ktrans had the second highest AUC=0.836 (p<0.001; cut-off=0.034 associated with an overall accuracy=79.6%, sensitivity=86.4%, specificity=74.1%, NPV=87.0% and PPV=73.1%). The other factors found to be acceptable diagnostic parameters for borderline/malignant lesions included WIR (AUC=0.816; p<0.001), iAUC60 (AUC=0.808; p<0.001), Vp (AUC=0.795; p<0.001), SI max (AUC=0.737, p=0.005), SI peak (AUC=0.737; p=0.005) and Kep (AUC=0.681; p=0.031). CONCLUSION: Quantitative DCE-MRI is a relevant tool for differentiating benign from malignant adnexal masses. Among all the DCE parameters, SI rel and Ktrans are the most accurate discriminators.
format Online
Article
Text
id pubmed-6948906
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-69489062020-02-04 Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI Gity, Masoumeh Parviz, Sara Saligheh Rad, Hamidreza Fathi Kazerooni, Anahita Shirali, Elham Shakiba, Madjid Baikpour, Masoud Asian Pac J Cancer Prev Research Article BACKGROUND: To evaluate the utility of the pharmacokinetic modeling derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiating benign from malignant adnexal masses. METHODS: A total of 43 patients with 49 complex adnexal masses (27 benign, 3 borderline, and 19 malignant lesions) underwent preoperative DCE-MRI examinations on a 3 Tesla MRI. Using extended Tofts’ model, quantitative analysis was performed in the solid components of all tumors. Three pharmacokinetic parameters were defined as volume transfer coefficient (Ktrans), the rate constant (Kep), and the plasma volume (Vp). Semi-quantitative analysis was also performed and the values of relative signal intensity (SI rel) wash-in-rate (WIR), the initial area under the curve (iAUC60), time-to-peak (TTP) and wash-out-rate (WOR) were calculated. Receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic characteristics of each DCE-MRI parameter in differentiating borderline/malignant tumors from benign lesions and to provide the optimal cutoff values for these variables. RESULTS: SI rel had the highest diagnostic value (AUC=0.872; p<0.001; cut-off=121.4 associated with an overall accuracy=79.6%, sensitivity=95.5%, specificity=66.7%, NPV=94.8% and PPV=70.0%). Ktrans had the second highest AUC=0.836 (p<0.001; cut-off=0.034 associated with an overall accuracy=79.6%, sensitivity=86.4%, specificity=74.1%, NPV=87.0% and PPV=73.1%). The other factors found to be acceptable diagnostic parameters for borderline/malignant lesions included WIR (AUC=0.816; p<0.001), iAUC60 (AUC=0.808; p<0.001), Vp (AUC=0.795; p<0.001), SI max (AUC=0.737, p=0.005), SI peak (AUC=0.737; p=0.005) and Kep (AUC=0.681; p=0.031). CONCLUSION: Quantitative DCE-MRI is a relevant tool for differentiating benign from malignant adnexal masses. Among all the DCE parameters, SI rel and Ktrans are the most accurate discriminators. West Asia Organization for Cancer Prevention 2019 /pmc/articles/PMC6948906/ /pubmed/31030476 http://dx.doi.org/10.31557/APJCP.2019.20.4.1073 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gity, Masoumeh
Parviz, Sara
Saligheh Rad, Hamidreza
Fathi Kazerooni, Anahita
Shirali, Elham
Shakiba, Madjid
Baikpour, Masoud
Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI
title Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI
title_full Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI
title_fullStr Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI
title_full_unstemmed Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI
title_short Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI
title_sort differentiation of benign from malignant adnexal masses by dynamic contrast-enhanced mri (dce-mri): quantitative and semi-quantitative analysis at 3-tesla mri
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948906/
https://www.ncbi.nlm.nih.gov/pubmed/31030476
http://dx.doi.org/10.31557/APJCP.2019.20.4.1073
work_keys_str_mv AT gitymasoumeh differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri
AT parvizsara differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri
AT salighehradhamidreza differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri
AT fathikazeroonianahita differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri
AT shiralielham differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri
AT shakibamadjid differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri
AT baikpourmasoud differentiationofbenignfrommalignantadnexalmassesbydynamiccontrastenhancedmridcemriquantitativeandsemiquantitativeanalysisat3teslamri